Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication.
Ruiz I, Nevers Q, Hernández E, Ahnou N, Brillet R, Softic L, Donati F, Berry F, Hamadat S, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Ruiz I, et al. Among authors: donati f. Antimicrob Agents Chemother. 2020 May 21;64(6):e02078-19. doi: 10.1128/AAC.02078-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32179525 Free PMC article.
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Nevers Q, Ruiz I, Ahnou N, Donati F, Brillet R, Softic L, Chazal M, Jouvenet N, Fourati S, Baudesson C, Bruscella P, Gelin M, Guichou JF, Pawlotsky JM, Ahmed-Belkacem A. Nevers Q, et al. Among authors: donati f. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00126-18. doi: 10.1128/AAC.00126-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29760125 Free PMC article.
Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues.
Chevaliez S, Rodriguez C, Poiteau L, Soulier A, Donati F, Darty-Mercier M, Pioche C, Leroy V, Brodard V, Zoulim F, Brouard C, Larsen C, Semaille C, Roudot-Thoraval F, Pawlotsky JM; Hepatology Reference Centers Laboratories Network for Chronic Hepatitis B Surveillance. Chevaliez S, et al. Among authors: donati f. J Viral Hepat. 2019 Feb;26(2):278-286. doi: 10.1111/jvh.13025. Epub 2018 Nov 14. J Viral Hepat. 2019. PMID: 30339311
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes.
Fourati S, Rodriguez C, Soulier A, Donati F, Hamadat S, Poiteau L, Demontant V, Brillet R, Ahnou N, Gricourt G, Chevaliez S, Ahmed-Belkacem A, Pawlotsky JM. Fourati S, et al. Among authors: donati f. Aliment Pharmacol Ther. 2020 Nov;52(10):1583-1591. doi: 10.1111/apt.16054. Epub 2020 Sep 4. Aliment Pharmacol Ther. 2020. PMID: 32886807
Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.
Ruiz I, Fourati S, Ahmed-Belkacem A, Rodriguez C, Scoazec G, Donati F, Soulier A, Demontant V, Poiteau L, N'Debi M, François M, Chevaliez S, Pawlotsky JM. Ruiz I, et al. Among authors: donati f. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e191-e196. doi: 10.1097/MEG.0000000000002003. Eur J Gastroenterol Hepatol. 2021. PMID: 33208686 Free PMC article.
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG; ROCnRAL ANRS-157 Study Group. Soulié C, et al. Among authors: donati f. J Antimicrob Chemother. 2015 Dec;70(12):3339-44. doi: 10.1093/jac/dkv280. Epub 2015 Sep 22. J Antimicrob Chemother. 2015. PMID: 26396157 Clinical Trial.
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
Singh M, Chazal M, Quarato P, Bourdon L, Malabat C, Vallet T, Vignuzzi M, van der Werf S, Behillil S, Donati F, Sauvonnet N, Nigro G, Bourgine M, Jouvenet N, Cecere G. Singh M, et al. Among authors: donati f. EMBO Rep. 2022 Feb 3;23(2):e54341. doi: 10.15252/embr.202154341. Epub 2021 Dec 16. EMBO Rep. 2022. PMID: 34914162 Free PMC article.
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F. Mac Kain A, et al. Among authors: donati f. Nat Commun. 2022 May 4;13(1):2442. doi: 10.1038/s41467-022-30134-9. Nat Commun. 2022. PMID: 35508460 Free PMC article.
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S. Grzelak L, et al. Among authors: donati f. Sci Transl Med. 2020 Sep 2;12(559):eabc3103. doi: 10.1126/scitranslmed.abc3103. Epub 2020 Aug 17. Sci Transl Med. 2020. PMID: 32817357 Free PMC article.
485 results